Enter email address
to receive updates from us
At Astellas, we never rest on our laurels. Through strategic partnerships and robust research, we are actively working to uncover new possibilities, from small-molecule synthesis and fermentation to monoclonal antibodies and genomics.
Our investment in research is a tangible example of our commitment to advancing the future—from the Miyukigaoka Research Center in Japan to the new Astellas Research Institute of America in Illinois—with over 20,000 square feet dedicated solely to transplant medicine.
- Expanded global research center with capacity for over 1,300 researchers
- Designed to be the most advanced transplant research center in the world
- Developed to improve and accelerate research and development
In addition to new molecule development, we are actively engaged in multiple phases of human clinical trials. This includes continuing our own trial exploration and supporting investigator-initiated trials. Our current research activity includes clinical trials at all 4 phases.
010A-032-1230 01/10